Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Treatment With Or Without Intravenous Alteplase In Acute Ischemic Stroke Of Basilar Artery Occlusion: A Multicenter, Prospective, Randomized Controlled Trial (BEST-BAO)

NCT05631847 is registered in ClinicalTrials.gov with Sichuan Academy of Medical Sciences as lead sponsor.

NCT NCT05631847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Treatment With Or Without Intravenous Alteplase In Acute Ischemic Stroke Of Basilar Artery Occlusion: A Multicenter, Prospective, Randomized Controlled Trial (BEST-BAO)
Lead sponsor
Sichuan Academy of Medical Sciences
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2023
Completion date
August 28, 2025
Enrollment
345 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, alteplase, basilar artery occlusion, endovascular treatment, thrombosis